| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7B | $5.5B | $5.9B | $6.4B | $7.0B | $7.3B | $2.0B | $2.1B |
| Cost of Revenue | $1.4B | $1.5B | $1.6B | $1.6B | $1.7B | $2.0B | $2.4B | $2.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.5B | $0.4B | $0.5B | $0.5B | $0.4B | $0.6B | $0.7B | $0.8B |
| Operating Income | $-1.0B | $2.1B | $-0.2B | $2.8B | $3.1B | $2.7B | $0.6B | $0.7B |
| Net Income | $-1.3B | — | — | — | — | — | $1.7B | $1.7B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.8B | $17.4B | $16.3B | $18.9B | $18.4B | $18.7B | $21.0B | $20.6B |
| Current Assets | $4.5B | $1.3B | $0.4B | $1.0B | $0.5B | $0.5B | $2.5B | $1.8B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.7B | $1.0B | $0.9B | $0.7B | $2.0B | $3.6B | $3.4B | $2.3B |
| Stockholders' Equity | $10.9B | $12.2B | $10.8B | $13.6B | $11.6B | $10.1B | $10.1B | $9.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $2.2B | $2.4B | $2.6B | $3.0B | $3.1B | $3.3B | $3.8B |
| Investing Cash Flow | $-1.5B | $-1.9B | $-0.5B | $-1.3B | $-0.8B | $0.8B | $-1.7B | $-1.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $-0.3B | $-1.9B | $-1.3B | $-2.3B | $-3.8B | $-1.6B | $-2.6B |